These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8123408)

  • 1. Effect of renal failure on drug metabolism by the liver.
    Elston AC; Bayliss MK; Park GR
    Br J Anaesth; 1993 Aug; 71(2):282-90. PubMed ID: 8123408
    [No Abstract]   [Full Text] [Related]  

  • 2. [Safe drug prescribing for patients with renal failure].
    Tanaka A; Shimizu H; Matsuo S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():58-66. PubMed ID: 18074518
    [No Abstract]   [Full Text] [Related]  

  • 3. [Guidelines for drug administration for dialysis patients].
    Nakamoto M
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():80-6. PubMed ID: 15250273
    [No Abstract]   [Full Text] [Related]  

  • 4. [Individualization of drug therapy in renal or liver insufficiency].
    Martin-Facklam M
    Ther Umsch; 2000 Sep; 57(9):568-72. PubMed ID: 11036437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic drug changes in patients with renal failure].
    Karie S; Launay-Vacher V; Kozlovskaia NL; Izzedine H; Deray G; Shilov EM
    Ter Arkh; 2005; 77(6):78-82. PubMed ID: 16078608
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.
    Matzke GR; Frye RF
    Drug Saf; 1997 Mar; 16(3):205-31. PubMed ID: 9098657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of mibefradil in hypertensive patients with varying degrees of renal insufficiency.
    Welker HA; Weidekamm E; Houwing N; de Chatel R
    Pharmacology; 1998 Jun; 56(6):297-307. PubMed ID: 9654216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor.
    Bergman AJ; Cote J; Yi B; Marbury T; Swan SK; Smith W; Gottesdiener K; Wagner J; Herman GA
    Diabetes Care; 2007 Jul; 30(7):1862-4. PubMed ID: 17468348
    [No Abstract]   [Full Text] [Related]  

  • 9. Single-dose pharmacokinetic studies of abiraterone acetate in men with hepatic or renal impairment.
    Marbury T; Lawitz E; Stonerock R; Gonzalez M; Jiao J; Breeding J; Haqq C; Verboven P; Stieltjes H; Yu M; Molina A; Acharya M; Chien C; Tran N
    J Clin Pharmacol; 2014 Jul; 54(7):732-41. PubMed ID: 24374856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.
    Lalonde RL; Wagner JA
    Clin Pharmacol Ther; 2009 Nov; 86(5):557-61. PubMed ID: 19776736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of drug administration in renal insufficiency.
    Lam YW; Banerji S; Hatfield C; Talbert RL
    Clin Pharmacokinet; 1997 Jan; 32(1):30-57. PubMed ID: 9012555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug pharmacokinetics in renal failure: What's new?].
    Naud J; Dumayne C; Nolin TD; Leblond FA; Pichette V
    Nephrol Ther; 2015 Jun; 11(3):144-51. PubMed ID: 25861715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics characterization of liposomal amphotericin B: investigation of clearance process and drug interaction potential.
    Matsui S; Imai S; Yabuki M; Komuro S
    Arzneimittelforschung; 2009; 59(9):461-70. PubMed ID: 19856794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of liver diseases on pharmacokinetics of drugs].
    Lazowski J; Rewerski W
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):95-9. PubMed ID: 2216955
    [No Abstract]   [Full Text] [Related]  

  • 15. [Renal insufficiency and drug metabolism].
    Balant LP
    Therapie; 1987; 42(4):393-7. PubMed ID: 3686475
    [No Abstract]   [Full Text] [Related]  

  • 16. Protein intake in renal and hepatic disease.
    Ambühl PM
    Int J Vitam Nutr Res; 2011 Mar; 81(2-3):162-72. PubMed ID: 22139567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute-on-chronic liver failure: the kidneys.
    Cárdenas A; Ginès P
    Curr Opin Crit Care; 2011 Apr; 17(2):184-9. PubMed ID: 21311322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
    Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):46-52. PubMed ID: 9825111
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of triptorelin after intravenous bolus administration in healthy males and in males with renal or hepatic insufficiency.
    Müller FO; Terblanchè J; Schall R; van Zyl Smit R; Tucker T; Marais K; Groenewoud G; Porchet HC; Weiner M; Hawarden D
    Br J Clin Pharmacol; 1997 Oct; 44(4):335-41. PubMed ID: 9354307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid renal excretion and renal insufficiency in decompensated severe heart failure.
    Ochiai ME; Barretto AC; Oliveira MT; Munhoz RT; Morgado PC; Ramires JA
    Eur J Heart Fail; 2005 Jun; 7(4):468-74. PubMed ID: 15921781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.